Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five:

1) Congress to Pass FDA User Fee Bill Without VALID Act, Again Putting Aside LDT Regulation

2) FDA Updates COVID-19 Test Emergency Use Authorization Policy

3) With COVID-19 Response Evolving, Next-Gen Dx Technologies Face Uncertain Future

4) Ravgen Wins $273M Award in Patent Infringement Suit Against Labcorp

5) Rice University, UConn Researchers Adapt CRISPR Enzyme to Create Ultra-Sensitive COVID-19 Test